Australia vs Guam: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Australia
0.1%
in 2024
Guam
0.1%
in 2024
Australia rank
112th
Guam rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Australia
- Guam
How they compare
Australia currently reports 0.1% against 0.1% in Guam, a difference of 0.0%.
Across all 10 years both countries report, Guam has been ahead every year.
Australia ranks 112th and Guam ranks 112th of 215 countries.
Guam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Guam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.5% | 0.4% | Guam |
| 2020s | 0.1% | 0.2% | 0.1% | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Australia or Guam?
- Australia, at 0.1% against 0.1% in Guam as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Australia and Guam?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Guam?
- 10 years are reported by both, from 2015 to 2024.
- How do Australia and Guam rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Australia ranks 112th and Guam ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.